12-Month results of the standardised combination therapy for diabetic macular oedema: Intravitreal bevacizumab and navigated retinal photocoagulation

Giulio Barteselli, Igor Kozak, Sharif El-Emam, Jay Chhablani, Marco A. Cortes, William R. Freeman

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: To evaluate the efficacy of a standardised combination therapy for clinically significant diabetic macular oedema using bevacizumab injections followed by navigated laser photocoagulation to stabilise retinal thickness. Methods: In this pilot study we retrospectively reviewed charts and imaging of 23 eyes treated with the standardised combination regimen. Eyes initially received monthly bevacizumab injections, followed by navigated laser photocoagulation when central retinal thickness (CRT) was

Original languageEnglish
Pages (from-to)1036-1041
Number of pages6
JournalBritish Journal of Ophthalmology
Volume98
Issue number8
DOIs
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of '12-Month results of the standardised combination therapy for diabetic macular oedema: Intravitreal bevacizumab and navigated retinal photocoagulation'. Together they form a unique fingerprint.

Cite this